Banner Image

Life Science

transaction loader

Tekla Healthcare Investors and Tekla Life Sciences Investors

Represented Tekla Healthcare Investors and Tekla Life Sciences Investors, closed-end funds focused on investments in public and private healthcare companies, in connection with their investments i...

n the Series E Preferred Stock financing of Sutro Biopharma,  a clinical stage drug discovery company creating protein therapeutics for oncology and autoimmune disorders.

Tekla Healthcare Investors and Tekla Life Sciences Investors

Represented Tekla Healthcare Investors and Tekla Life Sciences Investors, closed-end funds focused on investments in public and private healthcare companies, in connection with their investments i...

n the Series B Preferred financing of Amphivena Therapeutics, Inc., a clinical stage company developing treatments for blood cancers.

Tekla Healthcare Investors, Tekla Healthcare Opportunities Fund

Represented Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund, closed-end funds focused on investments in public and pr...

ivate healthcare companies, in connection with their investments in the Series C Preferred financing of Milestone Pharmaceuticals, Inc., a clinical stage cardiovascular company.

BioMed Venture AG

Represented BioMed Venture AG, a Hamburg, Germany based life science investment fund, in its investment in Intelligent Ion, Inc., a designer and manufacturer of miniaturized mass spectrometers.

Tarpan Therapeutics, inc.

Represented Tarpan Therapeutics, Inc., an early stage drug development company, in its merger with Manhattan Pharmaceuticals, Inc. (MHTT.OB).

Elan Corporation, plc

Represented Elan Corporation, plc, a worldwide pharmaceutical and biotechnology company, in the structuring and formation of joint ventures with U.S. biotechnology companies to develop and license...

new drug products and technologies.

Elite Pharmaceuticals, Inc.

Represented Elite Pharmaceuticals, Inc. (AMEX:ELI), a pharmaceutical company principally engaged in the development of oral, controlled release products, in a generic drug development arrangement ...

with Pliva, Inc.

Represented a private equity investor in the purchase of Class A Common Stock of AGI Genetics Incorporated Dermatics, a New York based company specializing in biomolecular research in dermatology ...

and skin care products.

Elan Corporation, plc

Represented Elan Corporation, plc, a worldwide pharmaceutical company, in the structuring and formation of joint ventures with U.S. pharmaceutical and biotechnology companies to develop and licens...

e new drug products and technologies.

Elite Pharmaceuticals, Inc.

Represented Elite Pharmaceuticals, Inc. (AMEX:ELI), a pharmaceutical company principally engaged in the development of oral, controlled release products, in a generic drug development arrangement ...

with IntelliPharmaCeutics Corp.

Elite Pharmaceuticals, Inc.

Represented Elite Pharmaceuticals, Inc. (AMEX:ELI), a pharmaceutical company principally engaged in the development of oral, controlled release products, in a generic drug development arrangement ...

with Harris Pharmaceutical, Inc. and Tish Technologies, LLC.

Kali Laboratories

Represented Kali Laboratories, a developer and manufacturer of generic drugs, in the acquisition of Kali by Par Pharmaceuticals (NYSE:PRX) for $140,000,000 in cash.